Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAbetes-PREvention Trial
NL-OMON21355Phase 4Active, not recruiting
- Sponsor
- Isala
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in prediabetes (2 arms), sponsored by Isala. Primary endpoint: Reduction in HbA1c at one year. Started Jul 2012; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NL-OMON21355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21355.